US › Healthcare

Vicarious Surgical Inc. (RBOT)

US · Healthcare · Medical Devices

$0.07+5.00%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$0
Net profit
$-7.3M
Profit YoY
+52.4%
EPS
$-1.65
EPS estimate
$-1.37

EPS came in at -1.65 against a street estimate of -1.37 — a miss of 20.4%.

Key statistics

Market cap
$541,982
Forward P/E
0.0
P/B
0.15
Book value
$0.50
EPS (TTM)
$-6.62
52-week high
$10.50
52-week low
$0.07
50-day MA
$0.36
200-day MA
$1.75
Beta
1.89

Analyst view

Analysts rate Vicarious Surgical Inc. a buy (1 buy, 2 hold, 0 sell out of 3) with an average price target of $5.00.

Shareholding

Insiders
14.84%
Institutions
16.34%

Largest institutional holders

FundStake
Aspex Management (HK) Ltd1.22%
Forum Finance Group S.A.0.05%
Rockefeller Capital Management L.P.0.01%
Daytona Street Capital LLC0.00%
Federation des caisses Desjardins du Quebec0.00%
SignatureFD, LLC0.00%
International Assets Investment Management, LLC0.00%
Sound Income Strategies0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Vicarious Surgical Inc. — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.